SOCIETY FOR MATERNAL-FETAL MEDICINE

Lobbying for SOCIETY FOR MATERNAL-FETAL MEDICINE

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 21, 2026

Expenses

$10,000.00

What this organization spent lobbying with its own staff. Reported using B: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 9

Agency for Healthcare Research & Quality (AHRQ)
Centers For Disease Control & Prevention (CDC)
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
Health Resources & Services Administration (HRSA)
HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Budget/Appropriations

FY 2027 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research & Quality, and the Health Resources and Services Administration

Health Issues

inclusion of pregnant and lactating women in clinical trials, federal support for maternal mortality review committees and perinatal quality collaboratives

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.